ARDEA BIOSCIENCES INC./DE (RDEA)
Symbol Info
Listed Symbol RDEA
Name ARDEA BIOSCIENCES INC./DE
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2011-12-01
Latest Fiscal Revenue $7,305,000
Latest Fiscal EPS $-3.26
Price Info
21 Day Moving Average $31.9643
21 Day EMA $31.869170
50 Day Moving Average $31.8656
50 Day EMA $30.481130
200 Day EMA $24.832800
200 Day Moving Average 22.122630
52 Week High $32.00
52 Week Low $13.15
52 Week Change $24.795000
Alpha 0.036191
Beta 1.1466
Standard Deviation 0.164386
R2 0.158255
Periods 56
Share Information
10 Day Average Volume -
20 Day Average Volume 179,053
30 Day Average Volume 248,514
50 Day Average Volume 568,269
Outstanding Shares 37,007,188
Float Shares 37,007,188
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 132
Institute Holdings Date 2012-05-01
Institute Bought Previous 3 Months 19,819,466
Institute Holdings Percent -
Institute Sold Previous 3 Months 1,816,517
Insider Holdings Date 2012-03-01
Insider Bought Previous 3 Months 1,341,470
Insider Holdings Percent 0.70%
Insider Sold Previous 3 Months 16,349
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $-0.0200005
21 Day Percent Change -0.06%
30 Day Price Change $0.0099983
30 Day Percent Change 0.03%
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $10.039999
90 Day Percent Change 45.80%
Quarter To Date $-
Quarter To Date Percent -
180 Day Price Change $15.830000
180 Day Percent Change 98.14%
200 Day Price Change $13.019999
200 Day Percent Change 68.74%
Year To Date $15.150000
Year To Date Percent 90.12%
Profile
Description
Details
Issue Type CS
Market Cap $1,182,749,728
Sec Type EQS
Auditor Marcum LLP
Total Shares Outstanding -
CEO Dr. Barry D. Quart,Pharm.D.
Employees 107
Last Audit UQ
Classification
CIK 0001103390
Industry
Sector
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 4939 Directors Place
San Diego, CA 92121
Website www.ardeabio.com
Facisimile (858) 652-0760
Telephone (858) 652-6500
Email jcapuzelo@ardeabio.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $7,011,000
Revenue Per Share $0.1894
Revenue 3 Years $191.87
Revenue 5 Years $72.25
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales 168.699140
Price To Free Cash -11.8
PE High Last 5 Years -
Price To Book 5.8
Price To Cash Flow -10.7
PE Low Last 5 Years -
Price To Tangible Book 5.8
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 9.6
Leverage Ratio 1.1
Quick Ratio 9.3
Long Term Debt To Capital -
Assets
Receivables Turnover 3.5
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -49.7
Return On Equity -
Return On Capital -55.4
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
RDEA
Ardea Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.